PharmExec Direct: Having trouble viewing the email? Click Here

In this ISSUE

No One Likes the Medicare Part B Pilot

UK: Industry Likely to Pay for NICE Technology Appraisals

2016 Emerging Pharma Leaders — Nominate Now

Top Story
Compounding: A Cause and Cure for High Drug Prices?
Just as insurers and regulators have sought to tamp down compounding costs and utilization, observers have begun to acknowledge that the practice may serve as an antidote to spiraling drug prices. John S. Linehan reports
... /Read more/
 
Advertisement
How On-Dose Technologies are Changing Pharmaceutical Product Intelligence and Security
On Demand
Read more
 
Digital Media & Marketing
Twitter at 10: Prodigy or Problem Child?
Twitter, ten years old this week, has earned a seat at the top table of digital media. But exactly where it sits for marketers remains somewhat uncertain, writes Peter Houston
... /Read more/
 
Advertisement
SPEED TO INSIGHT: 4 Strategies you need to maximize the value of your data assets
On Demand
Join Hewlett Packard Enterprise and Linguamatics as they discuss the right questions to ask about your company’s analytics capabilities to gain a competitive advantage.
Read more
 
Europe
Compassion and Calculation: The EU and Neglected Diseases
The failures in developing treatments for neglected diseases is perceived as a demonstration of the failure of the development model that richer countries have depended on, and which may also prove deficient in the face of evolving challenges. Reflector reports
... /Read more/
Q&A
Trusting Value, Valuing Trust
Pharm Exec talks to health economics pioneer Professor Bengt Jönsson of the Stockholm School of Economics about the latest thinking on value and its implications for industry, patients, and payers
... /Read more/
Emerging Pharma Leaders
Pharm Exec’s Emerging Pharma Leaders 2016 — Nominate Now
Pharm Exec is looking for the fresh faces of pharma leadership. And we'd like your input. Tell us who you think should be included as one of our 2016 Emerging Pharma Leaders. These leaders are vital to the future of the industry, and you can help ensure they get the recognition they deserve. Fill out your nomination today
... /Read more/
 
Calendar
/ April 18–19: IRT Europe — Interactive Response Technologies in Clinical Trials /
Brussels, Belgium
/ June 6–9: BIO International Convention /
San Francisco, CA.
/ June 21–22: Patient Engagement Solutions Summit /
Philadelphia, PA.
/ August 15–17: 10th Annual Forum on Transparency and Aggregate Spend /
Washington, DC.
/ December 13–14: Life Sciences Trade and Channel Strategies /
Philadelphia, PA
 
Industry update
//Inovio Pharmaceuticals, Inc. (Plymouth Meeting, PA) announced that David B. Weiner, Ph.D., recognized as the “father of DNA vaccines and immunotherapies,” has been appointed to its Board of Directors.//Halt Medical (Brentwood, CA) appointed Kim Bridges as Chief Executive Officer and member of the Board of Directors.//Advaxis, Inc. (Princeton, NJ) elected Gregory Mayes, Executive Vice President and Chief Operating Officer, to the company’s Board of Directors.//
 
advertise with us / print subscribe / digital subscribe / visit pharmexec.com